Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Hepatic Portal System01:21

Hepatic Portal System

6.4K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.4K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.8K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

619
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
619
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

981
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
981

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Supervised, Online, Home-Based Eccentric Resistance Exercise Program for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology research·2026
Same author

Haemochromatosis - a modern clinician's guide.

Internal medicine journal·2026
Same author

Arthritis and High Alcohol Intake at Diagnosis Increase Future Risk of Hepatocellular Carcinoma in <i>HFE</i> Hemochromatosis.

Gastro hep advances·2026
Same author

Reassessing Ferritin Levels in Healthy Older Adults: Updated Reference Ranges and Associated Health Outcomes.

Archives of pathology & laboratory medicine·2026
Same author

National survey of real-world treatment patterns for early- and intermediate-stage hepatocellular carcinoma reveals wide variation across Australian states.

Internal medicine journal·2026
Same author

Protective potential of minimally processed, plant-derived foods against steatotic liver disease in early adulthood.

Clinical nutrition ESPEN·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Hepatitis C.

John K Olynyk, Bruce R Bacon

    Postgraduate Medicine
    |December 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis C virus (HCV) infection is common and can cause serious liver disease. This review covers risk factors, chronicity likelihood, interferon therapy effectiveness, and emerging hepatitis C treatments.

    More Related Videos

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
    10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    10.3K
    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017

    10.8K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    24.7K
    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
    10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    10.3K
    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017

    10.8K

    Area of Science:

    • Hepatology
    • Virology
    • Infectious Diseases

    Background:

    • Hepatitis C virus (HCV) infection is a prevalent global health concern.
    • Significant liver disease, including cirrhosis and hepatocellular carcinoma, develops in up to 50% of infected individuals.
    • Recent advancements have led to an explosion of knowledge regarding HCV pathogenesis and management.

    Purpose of the Study:

    • To provide an updated overview of hepatitis C virus (HCV) infection.
    • To discuss risk factors associated with HCV acquisition and progression to chronic disease.
    • To review current and emerging treatment strategies for hepatitis C.

    Main Methods:

    • This article is a review synthesizing current knowledge on hepatitis C.
    • It addresses key questions regarding risk factors, chronicity, and treatment efficacy.
    • Information is drawn from recent scientific literature and clinical studies.

    Main Results:

    • HCV infection poses a significant risk for developing serious liver disease.
    • Understanding risk factors is crucial for prevention and early detection.
    • Interferon therapy effectiveness varies, influenced by patient-specific factors.

    Conclusions:

    • Hepatitis C management requires a comprehensive understanding of viral, host, and therapeutic factors.
    • New treatment strategies are under active investigation and show promise.
    • Continued research is essential to further improve outcomes for patients with hepatitis C.